CHI3L1 and myeloid sarcoma: In a meta-analysis of 64 articles including 4071 subjects of all MS subtypes, no significant differences in CSF levels of NfL and YKL-40 between RRMS and PMS patients were reported, although the study did not differentiate between PPMS and SPMS [80].